Pinnacle Associates LTD Astrazeneca PLC Transaction History
Pinnacle Associates LTD
- $7.15 Billion
- Q3 2025
A detailed history of Pinnacle Associates LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Pinnacle Associates LTD holds 29,114 shares of AZN stock, worth $2.6 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
29,114
Previous 29,634
1.75%
Holding current value
$2.6 Million
Previous $2.07 Million
7.87%
% of portfolio
0.03%
Previous 0.03%
Shares
35 transactions
Others Institutions Holding AZN
# of Institutions
1,501Shares Held
501MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...